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	 Total	cases	 Seizures	 Engel	I	 Engel	II+	
Before	Update	 	 	 	 	
Oligodendroglioma	 28	 18	 16	(89%)	 2	(11%)	
Astrocytoma	 24	 17	 11	(63%)	 6	(37%)	
Oligoastrocytoma	 11	 10	 6	(60%)	 4	(40%)	
	 	 	 	 	
After	Update	 	 	 	 	
Oligodendroglioma	 36	 24	 19	(79%)	 5	(21%)	
Astrocytoma	 27	 21	 14	(67%)	 7	(33%)	
II	 6	 3	 5	
II/III	 2	 	 	
III	 1	 1	 4	
III/IV	 	 	 1	




































































































































5.  Conclusion 
Our	data	are	consistent	with	similar	studies	when	assessing	seizure	outcome	after	resection	of	LGG,	
in	that	a	greater	EOR	gives	improved	seizure	freedom.	Even	when	EOR	was	subtotal,	most	patients	
were	still	Engel	class	I,	indicating	that	the	newer	strategy	of	earlier	and	more	aggressive	resection	
may	result	in	a	better	overall	prognosis	for	patients	with	LGGs	and	improve	quality	of	life	with	
regards	to	seizure	freedom.	Radiological	variables	did	not	impact	seizure	outcome,	indicating	that	
cautious	resection,	particularly	with	the	use	of	intra-operative	functional	mapping,	is	still	possible	in	
the	majority	of	tumours	even	when	eloquently	located.	Regardless	of	pre-operative	variables,	it	
appears	the	most	important	predictor	of	seizure	outcome	is	maximal	safe	resection,	regardless	of	
tumour	type.	
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